title: [Study on the therapy of nonmuscle-invasive bladder cancer: treatment of nonmuscle-invasive high-grade urothelial cancer of the bladder with the standard number and dosage of intravesical BCG instillations versus a reduced number of intravesical BCG instillations in the standard dosage: a randomized phase 3 study of the European Association of Urology Research Foundation (NIMBUS - AB 37/10 of the AUO)].
authors.affiliation: Geschäftsstelle der AUO, MeckEvidence, Seestraße 11, 17252, Schwarz, Deutschland, AUO@MeckEvidence.de.
authors.forename: H
authors.initials: H
authors.lastname: Rexer
mesh_terms: D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000382:microbiology / Q000473:pathology* / Q000628:therapy*; D019459:Urothelium / Q000382:microbiology / Q000473:pathology; D055815:Young Adult
chemical_list: D001500:BCG Vaccine; D019496:Cancer Vaccines